Biotech · Private company
Helixmith Co., Ltd.
Track this companyFree. Adds Helixmith Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials140 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- EngensisPhase 3 · Diabetic Peripheral NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- EngensisPhase 3 · Diabetic Neuropathy, PainfulClinicalTrials.gov · fetched Nov 12, 2026
- Engensis (VM202)Phase 3 · Painful Diabetic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- Engensis (VM202)Phase 3 · Foot Ulcer, DiabeticClinicalTrials.gov · fetched Nov 12, 2026
- Long-Term Follow-Up of Patients who Received Engensis (VM202)Phase 3 · Painful Diabetic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- EngensisPhase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- High Dose VM202Phase 2 · Critical Limb IschemiaClinicalTrials.gov · fetched Nov 12, 2026
- High Dose: 32 mg Engensis (VM202)Phase 2 · Painful Diabetic NeuropathiesClinicalTrials.gov · fetched Nov 12, 2026
- Low Dose VM202Phase 2 · Critical Limb IschemiaClinicalTrials.gov · fetched Nov 12, 2026
- Low Dose: 16 mg Engensis (VM202)Phase 2 · Painful Diabetic NeuropathiesClinicalTrials.gov · fetched Nov 12, 2026
- VM202Phase 2 · Painful Diabetic Peripheral NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- VM202Phase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- VM202Phase 2 · Myocardial IschemiaClinicalTrials.gov · fetched Nov 12, 2026
- VM202 16 mgPhase 1 · Critical Limb IschemiaClinicalTrials.gov · fetched Nov 12, 2026
- VM202 2 mgPhase 1 · Critical Limb IschemiaClinicalTrials.gov · fetched Nov 12, 2026
- VM202 4 mgPhase 1 · Critical Limb IschemiaClinicalTrials.gov · fetched Nov 12, 2026
- VM202 8 mgPhase 1 · Critical Limb IschemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials14
- A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral SclerosisPHASE2 · COMPLETED · started Nov 14, 2021ClinicalTrials.gov NCT05176093 · fetched Nov 12, 2026
- A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral NeuropathyPHASE3 · COMPLETED · started May 17, 2021ClinicalTrials.gov NCT04873232 · fetched Nov 12, 2026
- Safety of Engensis in Participants With Amyotrophic Lateral SclerosisPHASE2 · COMPLETED · started Mar 9, 2021ClinicalTrials.gov NCT04632225 · fetched Nov 12, 2026
- Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral NeuropathyPHASE3 · COMPLETED · started Nov 20, 2020ClinicalTrials.gov NCT04469270 · fetched Nov 12, 2026
- Extension of Phase 3 Gene Therapy for Painful Diabetic NeuropathyPHASE3 · COMPLETED · started Feb 4, 2019ClinicalTrials.gov NCT04055090 · fetched Nov 12, 2026
- Hepatocyte Growth Factor to Improve Functioning in PADPHASE2 · COMPLETED · started Jan 1, 2018ClinicalTrials.gov NCT03363165 · fetched Nov 12, 2026
- Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot UlcersPHASE3 · TERMINATED · started Jun 27, 2017ClinicalTrials.gov NCT02563522 · fetched Nov 12, 2026
- Phase 3 Gene Therapy for Painful Diabetic NeuropathyPHASE3 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02427464 · fetched Nov 12, 2026
- Gene Therapy for the Treatment of Chronic Stable AnginaPHASE1_PHASE2 · WITHDRAWN · started Mar 1, 2015ClinicalTrials.gov NCT01002495 · fetched Nov 12, 2026
- Safety Study of VM202 to Treat Amyotrophic Lateral SclerosisPHASE1_PHASE2 · COMPLETED · started Mar 11, 2014ClinicalTrials.gov NCT02039401 · fetched Nov 12, 2026
- Safety and Efficacy Study for the Treatment of Painful Diabetic NeuropathyPHASE2 · COMPLETED · started Aug 1, 2012ClinicalTrials.gov NCT01475786 · fetched Nov 12, 2026
- Safety and Efficacy Study Using Gene Therapy for Critical Limb IschemiaPHASE2 · COMPLETED · started Jul 9, 2010ClinicalTrials.gov NCT01064440 · fetched Nov 12, 2026
- Gene Therapy for Painful Diabetic NeuropathyPHASE1_PHASE2 · COMPLETED · started Feb 1, 2010ClinicalTrials.gov NCT01002235 · fetched Nov 12, 2026
- Safety Study of Gene Therapy in Treating Critical Leg IschemiaPHASE1 · COMPLETED · started Apr 3, 2007ClinicalTrials.gov NCT00696124 · fetched Nov 12, 2026